Point Of Care Testing Poct Market PowerPoint PPT Presentations

Europe POCT Devices Market has grown registering a robust CAGR of close to 8% during the review period. Currently, the market is in growth stage with high potential of future expansion in both developed and developing countries of the region.The report is useful for POCT Devices manufacturers, distributors, retailers, potential entrants and other stakeholders to align their market centric strategies according to ongoing and expected trends in the future.

Global Point of Care Testing Market is expected to reach USD 35.3 billion by 2024 from USD 18.6 billion in 2016, growing at a CAGR of 8.4% in the forecast period 2017 to 2024.

Global Point of Care Testing Market is expected to reach USD 35.3 billion by 2024 from USD 18.6 billion in 2016, growing at a CAGR of 8.4% in the forecast period 2017 to 2024.

Global Point-of-care Testing (POCT) Market By Product (Blood Glucose Testing Kits, Cardiometabolic Monitoring Kits, Infectious Disease Testing Kits, Cholesterol Testing Kits, Pregnancy & Fertility Tests Kits, Tumor/Cancer Markers, Urinalysis Testing Kits, Cholesterol Test Strips, Hematology Testing Kits, Drugs Of Abuse Testing Kits, Fecal Occult Testing Kits, Rapid Coagulation Testing Kits, & Others),By Prescription Mode (Prescription Based Testing & Over-The-Counter Testing),By Distribution Channel (Direct Tenders & Retail),By End User (Hospital, Clinics, Ambulatory Care, Home Healthcare, & Research Laboratory), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World) – Trends and Forecast to 2024

This TriMark Publications report “Point of Care Diagnostic Testing World Markets” describes latest developments in the point of care testing market segment. For more details : http://goo.gl/6pZ2p8

iGATE Research has released a research report on “Global Point of Care Testing Market (By Diagnostics Segment, Mode, End Users, Regions), 100 Company Profiles - Forecast to 2025” Click here to view the complete report: www.igateresearch.com Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-821-092-7469 (INDIA) Web: www.igateresearch.com

IIIIIIIIIIIIIIIIII Point of care testing (POCT) Dr K.A.C.Wickramaratne Definition Goals of POCT Uses Is it a rapid test? Tests available Advantages Disadvantages ...

ResearchAarkstore Enterprise European Point of Care Diagnostic Testing Markets 

ResearchAarkstore Enterprise European Point of Care Diagnostic Testing Markets .pptx

The concept of Point of Care Testing (POCT), also known as bedside, near-patient testing and decentralized testing, relates to tests that are conducted by clinical operators at the site of patient care where immediate medical action is taken on the results. The fact that point of care (POCT) represents a departure from conventional laboratory medicine has created new opportunities in the field of diagnostics industry. Technical advancements over recent years have helped point of care testing (POCT) to grow with double digit CAGR from 2009 to 2011 and evolve into a vital diagnostic tool. It is predicted that point of care testing market will be approximately US$ 25 Billion by 2016.

The Global Hepatitis Diagnostic Tests Market study focuses major leading industry players with information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. It provides information on trends and developments, and focuses on markets and materials, capacities and technologies, and on the changing structure.

Point of care testing (POCT) enables rapid diagnostic tests to be performed while the patient is at the point of care facility where results can be obtained immediately, rather than waiting hours or even days for outside lab results to arrive.

Access full Research: https://www.renub.com/point-of-care-testing-market-and-forecast-to-2016-global-analysis-158-p.php Point of Care Testing Market is anticipated to be US$ 36 Billion, by 2024 experiencing a significant growth over the forecast period. The concept of Point of Care Testing (POCT), also known as bedside, near-patient testing and decentralized testing, relates to tests that are conducted by clinical operators at the site of patient care where immediate medical action is taken on the results. The fact that point of care (POCT) represents a departure from conventional laboratory medicine has created new opportunities in the field of diagnostics industry.

Global Point of Care Technology Market Information by Product Type (Glucose Testing, Cardiac Markers, Hb1Ac Testing, Coagulation), by Instrument (Blood Glucose Meter), by End User (Clinics, Hospital, Home Care, Ambulatory Care) - Forecast to 2027

The report titled "India POCT Market Outlook to 2023" provides a comprehensive analysis on the Point of Care Testing Market of India.

For more Info: https://www.renub.com/point-of-care-testing-market-nd.php Point of care testing (POCT), also known as bedside testing is a medical diagnostic testing that allows patient diagnoses on the field, in the ambulance, at the physician’s office, in the hospital, or at home. The results of the point of care testing are timely and accurate which allow rapid treatment to the patient. Point of care testing has the potential to widely impact the health care delivery system by addressing the challenges of health disparities in real time. The success of the potential shift from remedial medicine to modified, prognostic and preventive medicine could rely on the enhancement of portable monitoring and diagnostic devices for point of care testing. Point of Care Testing Market is projected to reach US$ 36 Billion by the end of year 2024.

Identifying Growth Opportunities in Developing Economies: Developing economies represent significant growth opportunities for the data lake market, driven by factors such as increasing healthcare expenditure, rising disease burden, expanding middle-class populations, and government investments in healthcare infrastructure. However, challenges such as limited access to healthcare services, inadequate infrastructure, and socioeconomic disparities necessitate tailored strategies and innovative approaches to address the unique needs and constraints of developing economies. By leveraging technology, fostering public-private partnerships, and implementing scalable solutions, stakeholders can unlock growth opportunities and improve healthcare outcomes in emerging markets.

The global enteric disease testing market is projected to grow at a CAGR of 6.0% to reach USD 2.4 billion by 2026. The increasing food demand has compelled farmers, food manufacturers, and suppliers to increase the quantity and improve the quality of agricultural produce and food products.

Bharat Book Bureau provides the report, on “Research on Global Blood Testing Market (2014-2022) ” The Report state research on the Global Blood Testing Market is segmented on the basis of technology, type, end user and geography. On the basis of technology.

For each segment, this study examines the generally accepted clinical analytical activities in use today. For more details : http://goo.gl/Mzjrjw

Get a sample brochure @ http://tinyurl.com/h5mmm3c Home-care diagnostics and monitoring devices refer to a wide range of medical products (including heart rate monitors, blood glucose level indicators, and nebulizers), and services, that provide health monitoring, treatment, and physical support to individuals. People need not visit a hospital or any other healthcare facility to benefit from these offerings; they can be accessed with comfort at homes.

According to MRFR Analysis – blood testing market research is expected to accrue strong growth in forecast period 2017 to 2023. The global market research report provides in-depth industry analysis with free additional customization, including the impact of the COVID-19 pandemic.

Seasonal influenza continues to be one of the most common, and serious health conditions seen worldwide that even stands as a leading cause of mortality. The need for rapid critical diagnosis thus prevails, pushing the growth of rapid influenza diagnostic testing (RIDT) market.

The report on In-vitro Diagnostics Instruments Market by product (immunochemistry, clinical microbiology, POCT, tissue diagnostics, molecular diagnostics, hematology, hemostasis, SMBG), end user(hospitals and diagnostic laboratories, research institutes) trends analysis and forecasts up to 2023 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global In-vitro Diagnostics Instruments Market is projected to grow at a CAGR of 9.3% in terms of value over the period of 2017-2023. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.

China In Vitro Diagnostics Market will be USD 22.3 Billion by 2026. Forecast by Segment (Clinical Chemistry, Immunoassay, Molecular Testing, Microbiology, Hematology, SMBG, Point of Care Testing, Coagulation), Company Analysis.

In the past few years, the demand for point-of-care testing (POCT) has risen considerably, which is further creating need for portable and integrated devices. A POCT is a test which can be performed at or near the site of patient whenever the medical care is required. The technique has become an indicator of in vitro diagnosis, which is ascribed to its rapid, simple, low cost, and portable nature . The patient can be provided with result immediately outside of a laboratory, which is why POCT is also being widely utilized in hospitals as well. POCT further aids in improving patient care through remote patient care monitoring.

POINT OF CARE TESTING-POCT (an lisis junto al paciente) - Analizador port til de mano. ... PATIENT TESTING-NPT (an lisis cercano al paciente) - Analizadores de ...

Provided information to manufacturers, healthcare providers, and testing sites ... Hematology 28% Urine chemistry 15% Cardiac markers 4 ...

The global Tuberculosis Diagnostics Test Market is projected to reach USD 3.7 billion by 2032. This analysis covers revenue trends, pricing, market share, and growth rates. From 2024 to 2032, advancements in diagnostic technologies and increased adoption will drive market growth. The report highlights key players and strategic developments shaping the market's future.

Jouko Haapalahti, Assistant Vice President, Orion Diagnostica Oy, FIVDIC Chairman ... Estim 2003. Source: EDMA. Growth areas of IVD-testing. Point-of-Care testing ...

According to Renub Research market research report "Saudi Arabia In Vitro Diagnostics (IVD) Market, by Techniques (Immunochemistry, Clinical Chemistry, Hematology, Hemostasis, Microbiology, SMBG, POCT), Applications (Infectious, Cardiovascular Diseases), End User, Companies" Saudi Arabia In Vitro Diagnostics Market is forecasted to reach US$ 700 Million by the year 2024.

Clinical Laboratory Services Market

Market Size – USD 20.14 Billion in 2021, Market Growth – at a CAGR of 16.1%, Market Trends – Increasing application of microfluidic platforms in various healthcare industries

In-Vitro Diagnostic tests provide adequate information about the diseases without interacting directly to the human body. Saudi Arabia IVD Market is poised to reach US$ 700 Million by the year 2024. Renub Research report titled “Saudi Arabia In Vitro Diagnostics (IVD) Market, by Techniques, by Applications, by End User and by Companies (Roche, Abbott, Siemens Healthineers, Sysmex Corporation and Danaher Corporation)” provides a complete analysis of Saudi Arabia In-Vitro Diagnostics (IVD) Market. Access full Research: https://www.renub.com/saudi-arabia-in-vitro-diagnostics-market-p.php

South East Asia in vitro diagnostics market size is projected to exhibit a growth rate (CAGR) of 7.30% during 2024-2032.

The Diagnostic Lab Sector is experiencing significant growth, with projections indicating substantial expansion in the coming years. Valued at USD 84.18 billion in 2024, the market is expected to reach USD 109.92 billion by 2029, reflecting a robust compound annual growth rate (CAGR) of 5.48%.

Market Size – USD 9.51 billion in 2019, Market Growth - CAGR of 13.2%, Market Trends – Advancements in device technology.

Market Overview: Cancer Tissue Diagnostics Market Cancer tissue diagnostics play a pivotal role in oncology by facilitating accurate diagnosis, prognosis, and treatment selection based on tissue samples obtained from patients. The global cancer tissue diagnostics market is witnessing steady growth, driven by the increasing incidence of cancer, advancements in diagnostic technologies, and growing emphasis on personalized medicine.

Saudi Arabia In Vitro Diagnostics (IVD) Market, by Techniques (Immunochemistry, Clinical Chemistry, Hematology, Hemostasis, Microbiology, SMBG, POCT), Applications (Infectious, Cardiovascular Diseases), End User, Companies.

Molecular diagnostics, a rapidly evolving segment of the healthcare industry, utilizes molecular biology techniques to analyze biological markers at the molecular level. This approach enables precise detection, diagnosis, and monitoring of various diseases, leading to personalized treatment strategies and improved patient outcomes. The global molecular diagnostics market demonstrates robust growth, driven by technological advancements, increasing prevalence of infectious diseases and cancer, and growing demand for rapid and accurate diagnostic solutions. The global molecular diagnostics market is forecast to expand at a CAGR of 6.2% and thereby increase from a value of US$23.2 Bn in 2024, to US$35.6 Bn by the end of 2031.

The India Diagnostic Lab Market Size is estimated at USD 84.18 billion in 2024. Projections indicate further expansion, with expectations to reach USD 109.92 billion by 2029, representing a robust compound annual growth rate (CAGR) of 5.48% during the forecast period (2024-2029).

In Vitro Diagnostics Market USD 102.18 billion in 2024, poised for significant growth to USD 131.66 billion by 2029, with a notable CAGR of 5.20%. The catalyst for this growth is the global response to the COVID-19 pandemic.

iGATE Research has released a research report on “Food Safety Testing Market (by Contaminants, Pathogens, Type of Food Tested, Technology/Method, Region & Company Profile) and Forecast – Global Analysis to 2025” Click here to view the complete report: http://igateresearch.com/FullReportDetail.php?p=146 Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-821-092-7469 (INDIA) Web: www.igateresearch.com

China in vitro diagnostics(IVD) market is anticipated to grow over US$ 11 Billion by 2025 with an impressive double-digit growth rate in the forecast period 2018 - 2025. The market is driven by number of factors such as rising incidences of chronic lifestyle diseases, public health awareness, demand of tests in rural areas stimulated by the healthcare reform plan, increasing demand from the middle class for high–end products and an increase in the number of private hospitals and independent testing laboratories.

Global Biosensors Development & Demand Market, by Application (Medical Testing, Food Toxicity, Industrial Process),by Technology (Electrochemical Biosensors, Optical Biosensors, Thermal Biosensors), by End Users (Research Laboratories, Home Diagnostics, Food Industry) - Global Forecast 2027

iGATE RESEARCH report titled “China IVD Market and Forecast to 2020” is a 86 page report with 34 Figures and 1 Table. This report studies in details the China IVD Market - Application Segment Wise, China IVD Market - Company Sales, Development Environment and Regulatory Status in China IVD market and Driving Factors and Challenges for China IVD Market. Click here to view the complete report: http://www.igateresearch.com/ProductDetail.php?pd_name=China%20IVD%20Market%20and%20Forecast%20to%202020 Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-706-527-9335 (INDIA) Web: www.igateresearch.com

Noninvasive cancer diagnostics market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses the market to grow at a CAGR of 5.30% in the above-mentioned forecast period. https://www.databridgemarketresearch.com/reports/global-noninvasive-cancer-diagnostics-market

China In-Vitro Diagnostics (IVD) market is likely to more than triple by 2022 from its current level in 2016. China represents one of the largest clinical laboratory markets in the Asia-Pacific region, and the fastest growing among the top ten IVD country markets.

iGATE RESEARCH report titled “China IVD Market and Forecast to 2020” is a 86 page report with 34 Figures and 1 Table. This report studies in details the China IVD Market - Application Segment Wise, China IVD Market - Company Sales, Development Environment and Regulatory Status in China IVD market and Driving Factors and Challenges for China IVD Market. Click here to view the complete report: http://www.igateresearch.com/ProductDetail.php?pd_name=China%20IVD%20Market%20and%20Forecast%20to%202020 Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-706-527-9335 (INDIA) Web: www.igateresearch.com

Though the electric and hybrid bus market is in its initial phase but the rising venture funding and technological development are significantly driving the market. According to Goldstein Research, global electric & hybrid bus market is expected to reach 40,067 units by 2024, growing at a CAGR of 25.3% over the forecast period 2016-2024.

The global microfluidic device market was valued at USD 1,531.2 million in 2013. It is likely to grow at a CAGR of 22.8% during 2013 to 2019 to reach USD 5,246.4 million in 2019.

The report “Global In-Vitro Diagnostics (IVD) Market: Industry Analysis & Outlook (2017-2021)” analyzes the. For more mail: vikas@konceptanalytics.com

Global Market Estimates is a market research and business consulting company who has proven track record in serving Fortune 500 companies. Request for a sample copy of the ‘Automated Diagnosis Systems’ Market report@: https://www.globalmarketestimates.com/automated-diagnosis-systems-market/

Get more details @ http://bit.ly/2ePRhAo Some of the players in global molecular diagnostics market are Abbott Molecular, BioMerieux’s, Cepheid, Danaher Corporation, Qiagen Gaithersburg, Roche diagnostics, and Siemens Healthcare.

iGATE Research has released a research report on “China In-Vitro Diagnostics (IVD) Market, Size, Share, Trends, Regulations, Reimbursement & Key Players Analysis - Forecast to 2026” Click here to view the complete report: https://www.igateresearch.com/china-in-vitro-diagnostics-ivd-market-size-share-trends-regulations-reimbursement-key-players-analysis-forecast-to-2026.html Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-821-092-7469 (INDIA) Web: www.igateresearch.com

The emerging healthcare industry represents more than USD1.3 trillion and is growing at the rate of 6.8% across the globe. Out of which global medical device market in the year 2016 reached USD315 billion on the back of rapid advancement in medical devices technology